Your browser doesn't support javascript.
loading
Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma.
Witt, Kristina; Ligtenberg, Maarten A; Conti, Laura; Lanzardo, Stefania; Ruiu, Roberto; Wallmann, Tatjana; Tufvesson-Stiller, Helena; Chambers, Benedict J; Rolny, Charlotte; Lladser, Alvaro; Lundqvist, Andreas; Cavallo, Federica; Kiessling, Rolf.
Afiliação
  • Witt K; Department of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden.
  • Ligtenberg MA; Department of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden.
  • Conti L; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, Torino, Italy.
  • Lanzardo S; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, Torino, Italy.
  • Ruiu R; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, Torino, Italy.
  • Wallmann T; Department of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden.
  • Tufvesson-Stiller H; Department of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden.
  • Chambers BJ; Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden.
  • Rolny C; Department of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden.
  • Lladser A; Laboratory of Gene Immunotherapy; Fundación Ciencia and Vida; Santiago, Chile.
  • Lundqvist A; Department of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden.
  • Cavallo F; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, Torino, Italy.
  • Kiessling R; Department of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden. rolf.kiessling@ki.se.
Cancer Immunol Res ; 6(11): 1417-1425, 2018 11.
Article em En | MEDLINE | ID: mdl-30143536
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Células-Tronco Neoplásicas / Glicoproteínas de Membrana / Vacinas Anticâncer / Vacinas de DNA / Fator de Crescimento Epidérmico / Neoplasias Mamárias Experimentais / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Células-Tronco Neoplásicas / Glicoproteínas de Membrana / Vacinas Anticâncer / Vacinas de DNA / Fator de Crescimento Epidérmico / Neoplasias Mamárias Experimentais / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2018 Tipo de documento: Article